These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 6458120

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
    Summaria L, Boreisha IG, Arzadon L, Robbins KC.
    Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
    Anonick PK, Gonias SL.
    Biochem J; 1991 Apr 01; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
    Teisseyre E, Latallo ZS, Kopeć M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974 Apr 01; 101(1):99-110. PubMed ID: 4134484
    [No Abstract] [Full Text] [Related]

  • 11. The effect of streptokinase on the fibrin binding site of plasmin(ogen).
    Cederholm-Williams SA.
    Thromb Res; 1981 Mar 15; 21(6):649-54. PubMed ID: 6455776
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [On thrombolysis with various thrombolytic agents. I. Studies on experimental human natural blood clots].
    Schmidt HW.
    Klin Wochenschr; 1966 Jun 01; 44(11):618-21. PubMed ID: 4229084
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS, Rozenfeld MA, Leonova VB.
    Thromb Res; 1995 Apr 15; 78(2):173-87. PubMed ID: 7482434
    [Abstract] [Full Text] [Related]

  • 17. Staphylococcal clumping with soluble fibrin mmonomer complexes.
    Lipiński B, Hawiger J, Jeljaszewicz J.
    J Exp Med; 1967 Nov 01; 126(5):979-88. PubMed ID: 4228857
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y, Iwamoto M.
    Biochim Biophys Acta; 1970 Sep 29; 214(3):411-8. PubMed ID: 4251764
    [No Abstract] [Full Text] [Related]

  • 19. The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.
    Takada Y, Takada A.
    Thromb Res; 1989 Apr 15; 54(2):133-9. PubMed ID: 2526391
    [Abstract] [Full Text] [Related]

  • 20. Studies of 2 -macroglobulin in bovine plasma. 3. Its actions on bovine plasma kallikrein, plasmin and thrombin.
    Sugihara H, Nagasawa S, Suzuki T.
    J Biochem; 1971 Oct 15; 70(4):649-58. PubMed ID: 4257424
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.